Drug Database
Back to search

United States· US:70518-4089_3fa3ef1f-68ef-c73a-e063-6294a90a137a

TRANEXAMIC ACID

A tranexamic acid product containing tranexamic acid, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 15 of our 19 countries.

ATC B02AA02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedTRANEXAMIC ACIDATCB02AA02REGISTER NO.US:70518-4089_3fa3ef1…PACKS LISTED2CHECKEDAugust 23, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tranexamic acidAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tranexamic acid is registered in 15 of 19 countries.

Countries holding a registration under ATC B02AA02 (tranexamic acid), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 9 of them publish a price we can compare per daily dose
Search tranexamic acid products by name

Tranexamic acid · ATC B02AA02

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tranexamic acid costs, country by country.

Normalised to the WHO defined daily dose (2 g), the median price runs from $1.69 in Italy to $34.44 in Switzerland — a ×20 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Tranexamic acid · price per daily dose (2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$34.44
  • IT Italy$1.69
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
TRANEXAMIC ACID
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
B02AA02
ATC class
Tranexamic acid
Defined daily dose
2 g, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
August 23, 2026

Packs & prices · 2

  • ndc11
    7051840890
    10 CARTON in 1 BOX (70518-4089-0) / 1 VIAL, SINGLE-DOSE in 1 CARTON / 10 mL in 1 VIAL, SINGLE-DOSE (70518-4089-1)
  • ndc11
    70518-4089-0

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

45 interactions on record for tranexamic acid.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tranexamic acid against other medicinesHow interaction checks work

Tranexamic acid · interactions on record

45 records

  • 36 severe
  • 8 moderate
  • 1 minor

Most severe, free to view

  • Faktor VIII-Inhibitor Bypass Aktivität - FEIBAB02BD03severe
  • EstradiolD11AX34severe
  • IUP aus Plastik mit GestagenG02BA03severe
  • Levonorgestrel and ethinylestradiolG03AA07severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tranexamic acid in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tranexamic acid products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

  • Austria · Cyklokapron, Tranexamsäure Baxter
  • Belgium · Acide Tranexamique Kabi, Cyklokapron
  • Bulgaria · Медокапрон, Т-Капрон
  • Cyprus · Azeptil, Medsamic
  • Czechia · Exacyl, Tranexamic Acid Accord
  • Germany · Cyklokapron, Cyklokapron-Injektionslösung
  • Denmark · Cyklokapron, Cyklonova
  • Estonia · Cyklokapron, Medsamic
  • Spain · Ácido Tranexámico Baxter, Ácido Tranexámico Viatris
  • Finland · Caprilon, Cyklokapron
  • France · Acide Tranexamique Accord, Acide Tranexamique Aguettant
  • United Kingdom (Northern Ireland) · Cyklo-F, Cyklokapron
  • Greece · Tranexamic Acid /Kabi, Tranexamic Acid Baxter
  • Croatia · Medsamic, Trenolk
  • Hungary · Exacyl, Nimra
  • Ireland · Cyklokapron, Tranexamic Acid Accord Healthcare Ireland
  • Iceland · Cyklokapron, Tranexamsyre Pfizer
  • Italy · Acido Tranexamico Adamed, Acido Tranexamico Aurobindo
  • Lithuania · Haixa, Tranexamic Acid Baxter
  • Luxembourg · Exacyl, Tranexamsäure Dr. Eberth
  • Latvia · Cyklokapron, Haixa
  • Malta · Azeptil, Medsamic
  • Netherlands · Cyklokapron, Nexag
  • Norway · Cyklokapron, Pilexam
  • Poland · Deporium, Deporium Comfort
  • Portugal · Ácido Tranexâmico A.Forall, Ácido Tranexâmico Accord
  • Romania · Acid Tranexamic Kabi, Medsamic
  • Sweden · Cyklo-F, Cyklokapron
  • Slovenia · Medsamic, Trenolk
  • Slovakia · Medsamic, Tranexamic Acid Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0396ea8-9411-48df-975b-872f85bef608
GET /v1/drugs/d0396ea8-9411-48df-975b-872f85bef608?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "100",
  "substance": "TRANEXAMIC ACID",
  "productndc": "70518-4089",
  "dosage_form": "INJECTION",
  "dea_schedule": null,
  "strength_unit": "mg/mL",
  "application_number": "ANDA212360",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about tranexamic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console